Personalized Cancer Therapy: Research and Clinical Trials

PREDICT (Profile Related Evidence Determining Individualized Cancer Therapy)

Led by Razelle Kurzrock, MD, the purpose of this project is to determine the outcome of patients who had molecular profiling (genomic testing) performed and were treated with a matched targeted anticancer therapy. (See Molecular Tumor Board for additional information.)

Liquid Biopsy in Precision Cancer Medicine Program

Led by Hatim Husain, MD, and Razelle Kurzrock, MD, the objective of this aspect of the personalized cancer therapy program is to determine if genomics can be performed on blood samples and assist in predicting patient outcome or their response to treatment.

 

Contact Us

Debbie Lou, PhD
Program Director
dlou@ucsd.edu
858-246-1947

More Information

Molecular Tumor Board

In the News

PREDICT and Individual Genome Sequencing, La Jolla Light